Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group.[1] Simeen Rahman is the managing director and CEO of the company.[1][2]
History
Eskayef Bangladesh Ltd., a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990.[1] According to an IMS report, the company was among the top six pharmaceutical companies operating in Bangladesh in terms of sales in 2021.[3] By 2021, it exported finished products to 65 countries.[1] The company was renamed Eskayef Pharmaceuticals Limited in January 2017.[4]
Products
The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products[5] including the oral anti covid medication molnupiravir[6] & nirmatrelvir co-packaged with ritonavir and injectable remdesivir.
Further reading
External links
References
- Eskayef sales jump manifold The Daily Star, 2015-12-29, retrieved 2016-10-03^
- 'I am the brand' Prothom Alo, retrieved 2016-10-03^
- Sayeda Akter. Pharma industry set for expansion The Daily Star, 2009-08-23, retrieved 2016-10-03^
- Eskayef pledges to conquer odds with courage The Daily Star, 2017-01-24^
- Eskayef beats rivals in sales growth The Daily Star, 2012-01-26^
- Beximco, Eskayef to produce Covid drug businesspostbd.com, retrieved 2021-11-10^